Hemophilia: Understanding Inhibitors
Patients with hemophilia (a blood clotting disorder) can develop inhibitors (also called antibodies) when they have an immune response to factor concentrates (the treatment...
Understanding Blood Clots
As many as 900,000 people in the United States develop blood clots annually, and clots are
responsible for approximately 100,000 deaths each year. Research has...
Navigating Clinical Trials
A clinical trial is a controlled research study conducted by doctors and medical researchers to improve the care and treatment of people who have...
Women and the Risk of Blood Clots
Nearly 900,000 people are affected by blood clots each year, leading to approximately 100,000 blood clot-related deaths annually. Dangerous blood clots such as deep-vein...
The Pediatric Patient Living With Sickle Cell Disease
Sickle cell disease (SCD) is the most common genetic disorder in the United States, with about 100,000 American who have the disease and another...
Understanding Bone and Blood Marrow Transplants
Bone marrow is the soft tissue inside the bones that makes blood-forming cells known as blood stem cells. These grow into red blood cells...
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are cancers that affect the same lymphocytes, a type of white blood cell. CLL and...
What Is Acute Myeloid Leukemia?
Acute myeloid leukemia (AML) is the most common acute leukemia in the United States, comprising 33 percent of all leukemias. The cancer progresses rapidly...
Understanding Light Chain Amyloidosis
Amyloidosis is a rare disease that occurs due to a buildup of protein in different vital organs throughout the body. The disease is often...
Understanding Transplant in Lymphoma
Hematopoietic cell transplantation (HCT), also called stem cell or bone marrow transplantation, is a treatment option for patients with blood cancers such as leukemia,...
Current Issue
August 2020 Volume 6, Issue 10
This issue looks at the rapid expansion of telemedicine, explores access to leukemia treatment in Brazil, and more.
